PanAmerican Clinical Research

What PanAmerican Clinical Research does

PanAmerican Clinical Research is a woman-owned, multi-site clinical research organization founded in 2016 and headquartered in Brownsville, Texas. The company operates four physical research sites — Brownsville, TX; Bluffton, SC (opened February 2024); Guadalajara, MX; and Querétaro, MX — providing clinical-trial execution services to pharmaceutical, biotechnology, contract research organization (CRO), and government / global-health sponsors. Its core offering is site-based trial management combined with regulatory, community-engagement, and virtual-trial modules.

The company differentiates through a community-oriented, patient-centric operating model. All study coordinators are physicians (rather than non-clinical staff) and all personnel are bilingual English/Spanish. The network draws on 60+ specialty Principal Investigators and Sub-Investigators across 25+ therapeutic areas (cardiology, oncology, infectious disease, rheumatology, vaccines, and others). Site operations are supported by staff epidemiologists who map community disease prevalence for recruitment, mobile medical screening stations in underserved areas, and three in-house ethics committees registered with Mexico's COFEPRIS and CONBIOETICA. A recently launched Virtual Clinical Trial Model pairs in-home trial providers with a remote-visit platform to enable decentralized execution, including rare-disease studies otherwise considered infeasible. Adjacent service modules include regulatory submissions support, GCP auditing and training, customs brokerage for Latin American trials, and a contract CRA registry of senior certified physician-CRAs available worldwide.

The business model is professional-services based: PanAmerican generates revenue through per-trial fees for site management, patient recruitment and retention, data collection, regulatory compliance support, and monitoring on behalf of sponsors. Patient participation is free, with travel compensation; pricing for B2B sponsors is not publicly disclosed. Go-to-market is enterprise field sales: direct relationships with pharmaceutical and biotechnology sponsors and with CROs such as PPD and Syneos, supplemented by government and global-health engagements (e.g., the January 2024 strategic partnership with FHI Clinical for infectious-disease research in resource-limited regions). Documented sponsor outcomes — including Latin America becoming the highest-enrolling region of a global pediatric Phase III with fewest sites and no adverse audit findings, and enrollment completed in 10 months versus a two-year prior attempt for a large CRO — anchor the value proposition in measurable recruitment and quality advantages.

Name

PanAmerican Clinical Research

Legal name

PanAmerican Clinical Research, LLC

Website

https://panamclinicalresearch.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

51–100 employees

Short description

Woman-owned multi-site clinical research organization operating four sites across the United States and Mexico, executing pharmaceutical, biotech, CRO, and global-health clinical trials with a community-based patient-recruitment model focused on Hispanic populations.

Ownership category

akta.pro rank

Product category

Clinical Research Site Services

NAICS

Medical and Diagnostic Laboratories (6215), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industries

Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts) (HLAGACAC), Clinical Research & Trial Central Laboratories (HLAFAMAL), Clinical Trial Monitoring Support (On-site/Remote) (HLAGACAG)

Keywords

• Clinical trial site services
• Patient recruitment services
• Clinical research organization
• Decentralized clinical trials
• Latin America clinical research

Headquarters

HQ city

Brownsville

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Clinical Trial Services: PanAmerican provides clinical research services to pharmaceutical companies, CROs, and government organizations. Revenue is generated through fees for conducting clinical trials, including site management, patient recruitment, data collection, regulatory compliance, and monitoring services. As a clinical research site organization, they serve as the operational entity executing trials on behalf of sponsors.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels8 records

Core offering

PanAmerican Clinical Research is a multi-site clinical research site organization that operates physical research sites in the United States (Brownsville TX, Bluffton SC) and Mexico (Guadalajara, Querétaro) to conduct clinical trials on behalf of pharmaceutical sponsors, biotech firms, CROs, and government organizations. The company delivers site management, patient recruitment, study coordination, regulatory and ethics support, monitoring, and a hybrid virtual clinical trial model that leverages bilingual physician study coordinators to enroll diverse, typically underrepresented patient populations across 25+ therapeutic areas.

Product overview

PanAmerican Clinical Research is a multi-site clinical research organization offering a unified platform of clinical research services across the United States and Latin America. The core offering consists of physical research sites in Brownsville, TX; Bluffton, SC; Guadalajara, MX; and Querétaro, MX, supplemented by modular service offerings including clinical services (site management, study coordinators, monitoring), regulatory support, community engagement, and ethics committees. The company leverages its community-oriented, patient-centric approach to deliver quality data and exceptional recruitment/retention rates. Services span 60+ therapeutic specialties including cardiology, pulmonology, infectious disease, oncology, and rare diseases, with a focus on serving underserved populations through both traditional site-based trials and innovative virtual trial models.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• Latin America became the highest enrolling region in a global phase III pediatric trial, completed in least amount of time with fewest sites and no adverse audit findings
• +2 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• FHI ClinicalcoreStrategic or Co-development Partner · 11 January 2024Strategic partnership announced January 11, 2024 to propel global public health initiatives. Focus areas include infectious diseases like COVID, Dengue, Encephalitis, Malaria, Zika, neglected tropical diseases, and emerging diseases. Addresses critical health threats in resource-limited regions like Africa and Latin America. FHI Clinical brings experience with 500+ studies across 37 indications and 60+ clinical trials in past 5 years. PanAmerican brings Latin America presence, bilingual physician staff, and community-focused patient relationships.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• PPD (Thermo Fisher Scientific): Global CRO owned by Thermo Fisher Scientific, with extensive site management operations. Existing PanAmerican client; competes for the same large pharma Phase II/III work.
• ICON plc: Global CRO with broad site network and decentralized trial capabilities. Overlaps with PanAmerican in multi-TA trial execution and Latin American site coverage.
• Medpace: Mid-to-large global CRO with full-service clinical development capabilities including site management. Overlaps with PanAmerican as a sponsor-facing competitor that may absorb trial scope PanAmerican could otherwise execute.
• Syneos Health: Large CRO with site network spanning multiple therapeutic areas. Existing PanAmerican client/testimonial partner (Syneos publicly endorsed PanAmerican) and competitor for the same sponsor RFPs.
• Fortrea (formerly Labcorp Drug Development): Large global CRO offering site management, clinical operations, and central lab services. Competes for sponsor mandates across the same therapeutic breadth as PanAmerican, including Latin American coverage.

Direct peers

• FHI Clinical: Full-service CRO with deep experience in infectious disease and resource-limited settings. Direct strategic partner of PanAmerican (Jan 2024) and overlapping service offering in global health and infectious disease trials.
• Velocity Clinical Research: Multi-therapeutic SMO operating a large network of integrated research sites across the US. Direct peer to PanAmerican in the site-based clinical trial services market, though at significantly greater scale (dozens of sites).

Others

• IQVIA: World's largest CRO with extensive site network and proprietary technology platforms. Competes for the same sponsor site-selection decisions PanAmerican targets, with vastly greater scale and capital.
• ACM Global Laboratories: Central / specialty clinical trial laboratory operator. Adjacent to PanAmerican's on-site lab capabilities (PBMC processing, central lab support), and a potential complementary vendor or competing partner for sponsors seeking integrated site-lab services.

Emerging players

• EmVenio Research: Decentralized and community-based clinical research provider focused on diverse and underserved populations. Direct peer to PanAmerican's virtual trial model and Hispanic/community engagement approach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/panamericancrus
• Facebookfacebook.com/PanamClinicalUSA
• LinkedInlinkedin.com/company/panamerican-clinical-research
• Instagraminstagram.com/panamclinicalusa

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PanAmerican Clinical Research